Search Results for compound
Searching compound for Pyrazole-1-alanine returned 36219 results.
Displaying compounds 8501 - 8525 of 36219 in total
FDB009417
977011-13-4
(6R,7R)-7-[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(N-hydroxyimino)acetamido]-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
Matched name: … Fd&c blue no. 1, calcium lake …
Matched iupac: … (6R,7R)-7-[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(N-hydroxyimino)acetamido]-3-ethenyl-8-oxo-5-thia-1-azabicyclo …
Matched iupac: … (6R,7R)-7-[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(N-hydroxyimino)acetamido]-3-ethenyl-8-oxo-5-thia-1-azabicyclo …
FDB009552
16939-73-4
(2E)-hept-2-en-1-yl acetate
Matched synonyms: … 1-Acetate(2e)-2-hepten-1-ol ... 2-Hepten-1-ol, 1-acetate, (2E)- ... Acetate(e)-2-hepten-1-ol …
Matched name: … Hept-trans-2-en-1-yl acetate …
Matched iupac: … (2E)-hept-2-en-1-yl acetate …
Matched name: … Hept-trans-2-en-1-yl acetate …
Matched iupac: … (2E)-hept-2-en-1-yl acetate …
FDB010971
1076-38-6
2-hydroxy-4H-chromen-4-one
Matched synonyms: … 2-Hydroxy-4H-1-benzopyran-4-one ... 2H-1-Benzopyran-2,4(3H)-dione ... 3-(4-Hydroxyphenyl)-1-propane …
Matched name: … 4-Hydroxy-2H-1-benzopyran-2-one …
Matched description: … production leads to further fermentative production of the natural anticoagulant dicoumarol. 4-Hydroxy-2H-1- …
Matched name: … 4-Hydroxy-2H-1-benzopyran-2-one …
Matched description: … production leads to further fermentative production of the natural anticoagulant dicoumarol. 4-Hydroxy-2H-1- …
FDB014472
150-86-7
(2E)-3,7,11,15-tetramethylhexadec-2-en-1-ol
Matched synonyms: … 3,7,11,15-teramethyl-2-hexadecene-1-ol ... 3,7,11,15-Tetramethyl-2-hexadecen-1-ol ... 3,7,11,15-Tetramethylhexadec-2-en-1-ol …
Matched name: … (2E,7R,11R)-2-Phyten-1-ol …
Matched iupac: … (2E)-3,7,11,15-tetramethylhexadec-2-en-1-ol …
Matched name: … (2E,7R,11R)-2-Phyten-1-ol …
Matched iupac: … (2E)-3,7,11,15-tetramethylhexadec-2-en-1-ol …
3-methyl-2-sulfanylbutan-1-ol
Matched name: … xi-2-Mercapto-3-methyl-1-butanol …
Matched iupac: … 3-methyl-2-sulfanylbutan-1-ol …
Matched iupac: … 3-methyl-2-sulfanylbutan-1-ol …
(2S,4S,5R)-2-{[(2R,3R,4S,5S,6R)-2-{[(2S,3R,4R,5R,6R)-2-{[(2R,3S,4R,5R,6S)-4-{[(2S,4S,5R)-2-carboxy-5-acetamido-4-hydroxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxan-2-yl]oxy}-6-{[(2R,3S,4R,5R,6R)-4,5-dihydroxy-6-{[(2S,3R)-3-hydroxy-2-(octadec-11-enamido)octadecyl]oxy}-2-(hydroxymethyl)oxan-3-yl]oxy}-5-hydroxy-2-(hydroxymethyl)oxan-3-yl]oxy}-5-hydroxy-6-(hydroxymethyl)-3-(2-oxopropyl)oxan-4-yl]oxy}-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy}-5-acetamido-4-hydroxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxane-2-carboxylic acid
Matched name: … Ganglioside GD1a (d18:0/18:1(11Z)) …
Matched description: … Ganglioside GD1a (d18:0/18:1(11Z)) is a ganglioside. ... and semisynthetic gangliosides are considered possible therapeutics for neurodegenerative disorders.[1] ... In all Gangliosides, the ceramide is linked through its C-1 to a beta-glucosyl residue, which, in turn …
Matched description: … Ganglioside GD1a (d18:0/18:1(11Z)) is a ganglioside. ... and semisynthetic gangliosides are considered possible therapeutics for neurodegenerative disorders.[1] ... In all Gangliosides, the ceramide is linked through its C-1 to a beta-glucosyl residue, which, in turn …
(2S,4S,5R)-2-{[(2R,3R,4S,5S,6R)-2-{[(2S,3R,4R,5R,6R)-2-{[(2R,3S,4R,5R,6S)-4-{[(2S,4S,5R)-2-carboxy-5-acetamido-4-hydroxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxan-2-yl]oxy}-6-{[(2R,3S,4R,5R,6R)-6-{[(2S,3R)-2-(hexacos-17-enamido)-3-hydroxyoctadecyl]oxy}-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy}-5-hydroxy-2-(hydroxymethyl)oxan-3-yl]oxy}-5-hydroxy-6-(hydroxymethyl)-3-(2-oxopropyl)oxan-4-yl]oxy}-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy}-5-acetamido-4-hydroxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxane-2-carboxylic acid
Matched name: … Ganglioside GD1a (d18:0/26:1(17Z)) …
Matched description: … Ganglioside GD1a (d18:0/26:1(17Z)) is a ganglioside. ... and semisynthetic gangliosides are considered possible therapeutics for neurodegenerative disorders.[1] ... In all Gangliosides, the ceramide is linked through its C-1 to a beta-glucosyl residue, which, in turn …
Matched description: … Ganglioside GD1a (d18:0/26:1(17Z)) is a ganglioside. ... and semisynthetic gangliosides are considered possible therapeutics for neurodegenerative disorders.[1] ... In all Gangliosides, the ceramide is linked through its C-1 to a beta-glucosyl residue, which, in turn …
(2S,4S,5R)-2-{[(1S,2R)-1-[(3R,4S,6S)-6-carboxy-6-{[(2S,3R,4R,5S,6R)-2-{[(2R,3S,4R,5R,6R)-4,5-dihydroxy-6-{[(2S,3R)-3-hydroxy-2-(octadec-9-enamido)octadecyl]oxy}-2-(hydroxymethyl)oxan-3-yl]oxy}-3-hydroxy-5-{[(2S,3R,4R,5R,6R)-5-hydroxy-6-(hydroxymethyl)-3-(2-oxopropyl)-4-{[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-6-(hydroxymethyl)oxan-4-yl]oxy}-3-acetamido-4-hydroxyoxan-2-yl]-1,3-dihydroxypropan-2-yl]oxy}-5-acetamido-4-hydroxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxane-2-carboxylic acid
Matched name: … Ganglioside GD1b (d18:0/18:1(9Z)) …
Matched iupac: … (2S,4S,5R)-2-{[(1S,2R)-1-[(3R,4S,6S)-6-carboxy-6-{[(2S,3R,4R,5S,6R)-2-{[(2R,3S,4R,5R,6R)-4,5-dihydroxy …
Matched description: … Ganglioside GD1b (d18:0/18:1(9Z)) is a ganglioside. ... and semisynthetic gangliosides are considered possible therapeutics for neurodegenerative disorders.[1] ... In all Gangliosides, the ceramide is linked through its C-1 to a beta-glucosyl residue, which, in turn …
Matched iupac: … (2S,4S,5R)-2-{[(1S,2R)-1-[(3R,4S,6S)-6-carboxy-6-{[(2S,3R,4R,5S,6R)-2-{[(2R,3S,4R,5R,6R)-4,5-dihydroxy …
Matched description: … Ganglioside GD1b (d18:0/18:1(9Z)) is a ganglioside. ... and semisynthetic gangliosides are considered possible therapeutics for neurodegenerative disorders.[1] ... In all Gangliosides, the ceramide is linked through its C-1 to a beta-glucosyl residue, which, in turn …
(2S,4S,5R)-2-{[(2S,3R,4R,5S,6R)-2-{[(2R,3S,4R,5R,6R)-4,5-dihydroxy-6-{[(2S,3R)-3-hydroxy-2-(octadec-11-enamido)octadecyl]oxy}-2-(hydroxymethyl)oxan-3-yl]oxy}-3-hydroxy-5-{[(2S,3R,4R,5R,6R)-5-hydroxy-6-(hydroxymethyl)-3-(2-oxopropyl)-4-{[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-6-(hydroxymethyl)oxan-4-yl]oxy}-5-acetamido-4-hydroxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxane-2-carboxylic acid
Matched name: … Ganglioside GM1 (d18:0/18:1(11Z)) …
Matched description: … Ganglioside GM1 (d18:0/18:1(11Z)) is a ganglioside. ... [Wikipedia] Particularly, Ganglioside GM1 (d18:0/18:1(11Z)) is a GM1 Ganglioside. ... and semisynthetic gangliosides are considered possible therapeutics for neurodegenerative disorders.[1] …
Matched description: … Ganglioside GM1 (d18:0/18:1(11Z)) is a ganglioside. ... [Wikipedia] Particularly, Ganglioside GM1 (d18:0/18:1(11Z)) is a GM1 Ganglioside. ... and semisynthetic gangliosides are considered possible therapeutics for neurodegenerative disorders.[1] …
(2S,4S,5R)-5-acetamido-2-{[(2S,3R,4R,5S,6R)-2-{[(2R,3S,4R,5R,6R)-6-{[(2S,3R)-2-(hexacos-17-enamido)-3-hydroxyoctadecyl]oxy}-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy}-3-hydroxy-5-{[(2S,3R,4R,5R,6R)-5-hydroxy-6-(hydroxymethyl)-3-(2-oxopropyl)-4-{[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-6-(hydroxymethyl)oxan-4-yl]oxy}-4-hydroxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxane-2-carboxylic acid
Matched name: … Ganglioside GM1 (d18:0/26:1(17Z)) …
Matched description: … Ganglioside GM1 (d18:0/26:1(17Z)) is a ganglioside. ... [Wikipedia] Particularly, Ganglioside GM1 (d18:0/26:1(17Z)) is a GM1 Ganglioside. ... and semisynthetic gangliosides are considered possible therapeutics for neurodegenerative disorders.[1] …
Matched description: … Ganglioside GM1 (d18:0/26:1(17Z)) is a ganglioside. ... [Wikipedia] Particularly, Ganglioside GM1 (d18:0/26:1(17Z)) is a GM1 Ganglioside. ... and semisynthetic gangliosides are considered possible therapeutics for neurodegenerative disorders.[1] …
(2S,4S,5R)-5-acetamido-2-{[(2S,3R,4S,5S,6R)-2-{[(2R,3S,4R,5R,6R)-6-{[(2S,3R)-2-(hexacos-17-enamido)-3-hydroxyoctadecyl]oxy}-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy}-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy}-4-hydroxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxane-2-carboxylic acid
Matched name: … Ganglioside GM3 (d18:0/26:1(17Z)) …
Matched description: … Ganglioside GM3 (d18:0/26:1(17Z)) is a ganglioside. ... [Wikipedia] Particularly, Ganglioside GM3 (d18:0/26:1(17Z)) is a GM3 ganglioside. ... and semisynthetic gangliosides are considered possible therapeutics for neurodegenerative disorders.[1] …
Matched description: … Ganglioside GM3 (d18:0/26:1(17Z)) is a ganglioside. ... [Wikipedia] Particularly, Ganglioside GM3 (d18:0/26:1(17Z)) is a GM3 ganglioside. ... and semisynthetic gangliosides are considered possible therapeutics for neurodegenerative disorders.[1] …
(2S,4S,5R)-2-{[(1S,2R)-1-[(3R,4S,6S)-6-carboxy-6-{[(1S,2R)-1-[(3R,4S,6S)-6-carboxy-6-{[(2R,3S,4R,5R,6S)-3-{[(2S,3R,4R,5R,6R)-4-{[(2R,3R,4S,5S,6R)-4-{[(2S,4S,5R)-2-carboxy-5-acetamido-4-hydroxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxan-2-yl]oxy}-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-5-hydroxy-6-(hydroxymethyl)-3-(2-oxopropyl)oxan-2-yl]oxy}-6-{[(2R,3S,4R,5R,6R)-4,5-dihydroxy-6-{[(2S,3R)-3-hydroxy-2-(octadec-9-enamido)octadecyl]oxy}-2-(hydroxymethyl)oxan-3-yl]oxy}-5-hydroxy-2-(hydroxymethyl)oxan-4-yl]oxy}-3-acetamido-4-hydroxyoxan-2-yl]-1,3-dihydroxypropan-2-yl]oxy}-3-acetamido-4-hydroxyoxan-2-yl]-1,3-dihydroxypropan-2-yl]oxy}-5-acetamido-4-hydroxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxane-2-carboxylic acid
Matched name: … Ganglioside GQ1c (d18:0/18:1(9Z)) …
Matched iupac: … (2S,4S,5R)-2-{[(1S,2R)-1-[(3R,4S,6S)-6-carboxy-6-{[(1S,2R)-1-[(3R,4S,6S)-6-carboxy-6-{[(2R,3S,4R,5R,6S …
Matched description: … Ganglioside GQ1c (d18:0/18:1(9Z)) is a ganglioside. ... and semisynthetic gangliosides are considered possible therapeutics for neurodegenerative disorders.[1] ... In all Gangliosides, the ceramide is linked through its C-1 to a beta-glucosyl residue, which, in turn …
Matched iupac: … (2S,4S,5R)-2-{[(1S,2R)-1-[(3R,4S,6S)-6-carboxy-6-{[(1S,2R)-1-[(3R,4S,6S)-6-carboxy-6-{[(2R,3S,4R,5R,6S …
Matched description: … Ganglioside GQ1c (d18:0/18:1(9Z)) is a ganglioside. ... and semisynthetic gangliosides are considered possible therapeutics for neurodegenerative disorders.[1] ... In all Gangliosides, the ceramide is linked through its C-1 to a beta-glucosyl residue, which, in turn …
(2S,4S,5R)-2-{[(1S,2R)-1-[(3R,4S,6S)-6-carboxy-6-{[(1S,2R)-1-[(3R,4S,6S)-6-carboxy-6-{[(2R,3S,4R,5R,6S)-3-{[(2S,3R,4R,5R,6R)-4-{[(2R,3R,4S,5S,6R)-4-{[(2S,4S,5R)-2-carboxy-5-acetamido-4-hydroxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxan-2-yl]oxy}-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-5-hydroxy-6-(hydroxymethyl)-3-(2-oxopropyl)oxan-2-yl]oxy}-6-{[(2R,3S,4R,5R,6R)-6-{[(2S,3R)-2-(docos-13-enamido)-3-hydroxyoctadecyl]oxy}-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy}-5-hydroxy-2-(hydroxymethyl)oxan-4-yl]oxy}-3-acetamido-4-hydroxyoxan-2-yl]-1,3-dihydroxypropan-2-yl]oxy}-3-acetamido-4-hydroxyoxan-2-yl]-1,3-dihydroxypropan-2-yl]oxy}-5-acetamido-4-hydroxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxane-2-carboxylic acid
Matched name: … Ganglioside GQ1c (d18:0/22:1(13Z)) …
Matched iupac: … (2S,4S,5R)-2-{[(1S,2R)-1-[(3R,4S,6S)-6-carboxy-6-{[(1S,2R)-1-[(3R,4S,6S)-6-carboxy-6-{[(2R,3S,4R,5R,6S …
Matched description: … Ganglioside GQ1c (d18:0/22:1(13Z)) is a ganglioside. ... and semisynthetic gangliosides are considered possible therapeutics for neurodegenerative disorders.[1] ... In all Gangliosides, the ceramide is linked through its C-1 to a beta-glucosyl residue, which, in turn …
Matched iupac: … (2S,4S,5R)-2-{[(1S,2R)-1-[(3R,4S,6S)-6-carboxy-6-{[(1S,2R)-1-[(3R,4S,6S)-6-carboxy-6-{[(2R,3S,4R,5R,6S …
Matched description: … Ganglioside GQ1c (d18:0/22:1(13Z)) is a ganglioside. ... and semisynthetic gangliosides are considered possible therapeutics for neurodegenerative disorders.[1] ... In all Gangliosides, the ceramide is linked through its C-1 to a beta-glucosyl residue, which, in turn …
(2S,4S,5R)-2-{[(1S,2R)-1-[(3R,4S,6S)-6-carboxy-6-{[(2R,3S,4R,5R,6S)-3-{[(2S,3R,4R,5R,6R)-4-{[(2R,3R,4S,5S,6R)-4-{[(2S,4S,5R)-2-carboxy-5-acetamido-4-hydroxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxan-2-yl]oxy}-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-5-hydroxy-6-(hydroxymethyl)-3-(2-oxopropyl)oxan-2-yl]oxy}-6-{[(2R,3S,4R,5R,6R)-6-{[(2S,3R)-2-(docos-13-enamido)-3-hydroxyoctadecyl]oxy}-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy}-5-hydroxy-2-(hydroxymethyl)oxan-4-yl]oxy}-3-acetamido-4-hydroxyoxan-2-yl]-1,3-dihydroxypropan-2-yl]oxy}-5-acetamido-4-hydroxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxane-2-carboxylic acid
Matched name: … Ganglioside GT1b (d18:0/22:1(13Z)) …
Matched iupac: … (2S,4S,5R)-2-{[(1S,2R)-1-[(3R,4S,6S)-6-carboxy-6-{[(2R,3S,4R,5R,6S)-3-{[(2S,3R,4R,5R,6R)-4-{[(2R,3R,4S …
Matched description: … Ganglioside GT1b (d18:0/22:1(13Z)) is a ganglioside. ... and semisynthetic gangliosides are considered possible therapeutics for neurodegenerative disorders.[1] ... In all Gangliosides, the ceramide is linked through its C-1 to a beta-glucosyl residue, which, in turn …
Matched iupac: … (2S,4S,5R)-2-{[(1S,2R)-1-[(3R,4S,6S)-6-carboxy-6-{[(2R,3S,4R,5R,6S)-3-{[(2S,3R,4R,5R,6R)-4-{[(2R,3R,4S …
Matched description: … Ganglioside GT1b (d18:0/22:1(13Z)) is a ganglioside. ... and semisynthetic gangliosides are considered possible therapeutics for neurodegenerative disorders.[1] ... In all Gangliosides, the ceramide is linked through its C-1 to a beta-glucosyl residue, which, in turn …
(2S,4S,5R)-2-{[(1S,2R)-1-[(3R,4S,6S)-6-carboxy-6-{[(1S,2R)-1-[(3R,4S,6S)-6-carboxy-6-{[(2S,3R,4S,5S,6R)-2-{[(2R,3S,4R,5R,6R)-4,5-dihydroxy-6-{[(2S,3R)-3-hydroxy-2-(octadec-11-enamido)octadecyl]oxy}-2-(hydroxymethyl)oxan-3-yl]oxy}-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy}-3-acetamido-4-hydroxyoxan-2-yl]-1,3-dihydroxypropan-2-yl]oxy}-3-acetamido-4-hydroxyoxan-2-yl]-1,3-dihydroxypropan-2-yl]oxy}-5-acetamido-4-hydroxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxane-2-carboxylic acid
Matched name: … Ganglioside GT3 (d18:0/18:1(11Z)) …
Matched iupac: … (2S,4S,5R)-2-{[(1S,2R)-1-[(3R,4S,6S)-6-carboxy-6-{[(1S,2R)-1-[(3R,4S,6S)-6-carboxy-6-{[(2S,3R,4S,5S,6R …
Matched description: … Ganglioside GT3 (d18:0/18:1(11Z)) is a ganglioside. ... and semisynthetic gangliosides are considered possible therapeutics for neurodegenerative disorders.[1] ... [Wikipedia] Particularly, Ganglioside GT3 (d18:0/18:1(11Z)) is a GT3 ganglioside, A glycosphingolipid …
Matched iupac: … (2S,4S,5R)-2-{[(1S,2R)-1-[(3R,4S,6S)-6-carboxy-6-{[(1S,2R)-1-[(3R,4S,6S)-6-carboxy-6-{[(2S,3R,4S,5S,6R …
Matched description: … Ganglioside GT3 (d18:0/18:1(11Z)) is a ganglioside. ... and semisynthetic gangliosides are considered possible therapeutics for neurodegenerative disorders.[1] ... [Wikipedia] Particularly, Ganglioside GT3 (d18:0/18:1(11Z)) is a GT3 ganglioside, A glycosphingolipid …
FDB028933
852100-88-0
[(2R,5S,6R)-2-{[(2S,3R,4E)-2-dodecanamido-3-hydroxyoctadec-4-en-1-yl]oxy}-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxidanesulfonic acid
Matched synonyms: … Sulfatide (d18:1/12:0) ... N-[(1S,2R,3E)-2-hydroxy-1-[[(3-O-sulfo-b-D-galactopyranosyl)oxy]methyl]-3-heptadecen-1-yl]-Undecanamide ... N-[(1S,2R,3E)-2-hydroxy-1-[[(3-O-sulfo-beta-delta-galactopyranosyl)oxy]methyl]-3-heptadecen-1-yl]-Undecanamide …
Matched name: … 3-O-Sulfogalactosylceramide (d18:1/12:0) …
Matched iupac: … [(2R,5S,6R)-2-{[(2S,3R,4E)-2-dodecanamido-3-hydroxyoctadec-4-en-1-yl]oxy}-3,5-dihydroxy-6-(hydroxymethyl …
Matched name: … 3-O-Sulfogalactosylceramide (d18:1/12:0) …
Matched iupac: … [(2R,5S,6R)-2-{[(2S,3R,4E)-2-dodecanamido-3-hydroxyoctadec-4-en-1-yl]oxy}-3,5-dihydroxy-6-(hydroxymethyl …
FDB028934
151122-71-3
[(2R,5S,6R)-3,5-dihydroxy-2-{[(2S,3R,4E)-3-hydroxy-2-tetradecanamidooctadec-4-en-1-yl]oxy}-6-(hydroxymethyl)oxan-4-yl]oxidanesulfonic acid
Matched synonyms: … Sulfatide (d18:1/14:0) ... N-[(1S,2R,3E)-2-hydroxy-1-[[(3-O-sulfo-b-D-galactopyranosyl)oxy]methyl]-3-heptadecen-1-yl]-Tetradecanamide ... N-[(1S,2R,3E)-2-hydroxy-1-[[(3-O-sulfo-beta-delta-galactopyranosyl)oxy]methyl]-3-heptadecen-1-yl]-Tetradecanamide …
Matched name: … 3-O-Sulfogalactosylceramide (d18:1/14:0) …
Matched iupac: … [(2R,5S,6R)-3,5-dihydroxy-2-{[(2S,3R,4E)-3-hydroxy-2-tetradecanamidooctadec-4-en-1-yl]oxy}-6-(hydroxymethyl …
Matched name: … 3-O-Sulfogalactosylceramide (d18:1/14:0) …
Matched iupac: … [(2R,5S,6R)-3,5-dihydroxy-2-{[(2S,3R,4E)-3-hydroxy-2-tetradecanamidooctadec-4-en-1-yl]oxy}-6-(hydroxymethyl …
FDB028937
265096-81-9
[(2R,5S,6R)-3,5-dihydroxy-2-{[(2S,3R,4E)-3-hydroxy-2-icosanamidooctadec-4-en-1-yl]oxy}-6-(hydroxymethyl)oxan-4-yl]oxidanesulfonic acid
Matched synonyms: … Sulfatide (d18:1/20:0) ... N-[(1S,2R,3E)-2-hydroxy-1-[[(3-O-sulfo-b-D-galactopyranosyl)oxy]methyl]-3-heptadecen-1-yl]-Eicosanamide ... N-[(1S,2R,3E)-2-hydroxy-1-[[(3-O-sulfo-beta-delta-galactopyranosyl)oxy]methyl]-3-heptadecen-1-yl]-Eicosanamide …
Matched name: … 3-O-Sulfogalactosylceramide (d18:1/20:0) …
Matched iupac: … [(2R,5S,6R)-3,5-dihydroxy-2-{[(2S,3R,4E)-3-hydroxy-2-icosanamidooctadec-4-en-1-yl]oxy}-6-(hydroxymethyl …
Matched name: … 3-O-Sulfogalactosylceramide (d18:1/20:0) …
Matched iupac: … [(2R,5S,6R)-3,5-dihydroxy-2-{[(2S,3R,4E)-3-hydroxy-2-icosanamidooctadec-4-en-1-yl]oxy}-6-(hydroxymethyl …
[3-(hexadecanoyloxy)-2-[(11Z)-octadec-11-enoyloxy]propoxy][2-(methylamino)ethoxy]phosphinic acid
Matched name: … PE-NMe(16:0/18:1(11Z)) …
[3-(hexadecanoyloxy)-2-[(11Z)-icos-11-enoyloxy]propoxy][2-(methylamino)ethoxy]phosphinic acid
Matched name: … PE-NMe(16:0/20:1(11Z)) …
[2-(methylamino)ethoxy]({2-[(11Z)-octadec-11-enoyloxy]-3-(octadecanoyloxy)propoxy})phosphinic acid
Matched name: … PE-NMe(18:0/18:1(11Z)) …
[2-(dimethylamino)ethoxy]({2-[(11Z)-octadec-11-enoyloxy]-3-(octadecanoyloxy)propoxy})phosphinic acid
Matched name: … PE-NMe2(18:0/18:1(11Z)) …
{2-[(11Z)-icos-11-enoyloxy]-3-(octadecanoyloxy)propoxy}[2-(methylamino)ethoxy]phosphinic acid
Matched name: … PE-NMe(18:0/20:1(11Z)) …
[2-(dimethylamino)ethoxy]({2-[(13Z)-icos-13-enoyloxy]-3-(octadecanoyloxy)propoxy})phosphinic acid
Matched name: … PE-NMe2(18:0/20:1(13Z)) …
[2-(dimethylamino)ethoxy][2-(docosanoyloxy)-3-[(9Z)-octadec-9-enoyloxy]propoxy]phosphinic acid
Matched name: … PE-NMe2(18:1(9Z)/22:0) …